Durable stabilization of three chordoma cases by bevacizumab and erlotinib.
Department of Radiation Sciences, Umeå University , Umeå , Sweden.
T
T
Asklund
M
M
Sandström
S
S
Shahidi
K
K
Riklund
R
R
Henriksson
D000328:Adult; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D000068258:Bevacizumab; D001859:Bone Neoplasms / Q000188:drug therapy* / Q000601:surgery; D002817:Chordoma / Q000188:drug therapy* / Q000601:surgery; D000069347:Erlotinib Hydrochloride; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011799:Quinazolines / Q000627:therapeutic use*; D012447:Sacrum / Q000601:surgery; D012888:Skull Neoplasms / Q000188:drug therapy*; D016896:Treatment Outcome
D061067:Antibodies, Monoclonal, Humanized; D011799:Quinazolines; D000068258:Bevacizumab; D000069347:Erlotinib Hydrochloride